Long‐Term Dupilumab Efficacy and Safety in Pediatric Patients: A Real‐World Experience Over 2 Years

Documenti analoghi

• Long‐Term Safety and Efficacy of Dupilumab in Pediatric Atopic Dermatitis Patients
  di: Hilla Bauch-Eigner, et al.
  Pubblicazione: (2025)
• Long‐Term Real‐World Safety Profile of Secukinumab Assessed Through a 9‐Year Experience in Patients Affected by Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Results From a Multicentric Retrospective Study
  di: Elena Ippoliti, et al.
  Pubblicazione: (2025)
• Long‐Term Effectiveness and Safety of Dupilumab for the Treatment of Prurigo Nodularis
  di: Elena Ippoliti, et al.
  Pubblicazione: (2025)
• The Clinical Efficacy and Safety of Dupilumab Monotherapy in Dystrophic Epidermolysis Bullosa: A Retrospective Real‐World Study
  di: Jian-Bo Wang, et al.
  Pubblicazione: (2026)
• Large language models and dermoscopy: Assessing the potential of task‐specific GPT‐4 vision in diagnosing basal cell carcinoma
  di: Daniele Omar Traini, et al.
  Pubblicazione: (2024)